Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences

    NEXT STORY
    BeiGene Announces the Approval of BRUKINSA™ (Zanubrutinib) in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma
    PREV STORY
    Teleflex to Present at the Raymond James 2020 Human Health Innovation Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Oasmia Pharmaceutical Strengthens its Management Team and Organization

    author_avatar
    NASDAQ Market News

    Global Wireless Health and Fitness Devices Industry

    author_avatar
    NASDAQ Market News

    LipoMedix Announces Manufacturing Agreement with ForDoz for Promitil®

    author_avatar
    NASDAQ Market News